Polymorphisms and circulating levels in the insulin-like growth factor system and risk of breast cancer: a systematic review.

We reviewed all English-language articles on associations among circulating levels of the insulin-like growth factors (IGF) and their binding proteins (IGFBP), polymorphisms in their genes, and breast cancer risk. In premenopausal women, five of eight IGF-I studies and four of six IGFBP-3 studies of circulating levels found that women in the highest quantile had more than twice the risk of developing breast cancer of those in the lowest, although in some this effect was only apparent at young ages. In postmenopausal women, however, there was no consistent effect. A simple sequence length polymorphism 1 kb 5' to IGF-I was examined in relation to circulating levels of IGF-I (12 studies) or breast cancer risk (4 studies), but there was no convincing evidence of any effect. For an A/C polymorphism 5' to IGFBP-3, all three studies were consistent with a modest effect on circulating levels, but no evidence of a direct effect on breast cancer risk was seen in the only relevant study. Variation within the reference range of IGF-I and IGFBP-3 may confer only modest increases in breast cancer risk, and any single polymorphism may only account for a small proportion of that variation. Nevertheless, population attributable fractions for high circulating levels of IGF-I and IGFBP-3 and for common genetic variants could be substantial. Further large studies, or combined analysis of data from existing studies, are needed to quantify these effects more precisely.

[1]  G. Colditz,et al.  The HRAS1 variable number of tandem repeats and risk of breast cancer. , 2003, Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology.

[2]  D. Hunter,et al.  Polymorphic variation at the ‐202 locus in IGFBP3: Influence on serum levels of insulin‐like growth factors, interaction with plasma retinol and vitamin D and breast cancer risk , 2003, International journal of cancer.

[3]  X. Shu,et al.  Joint effect of insulin-like growth factors and sex steroids on breast cancer risk. , 2003, Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology.

[4]  D. Altman,et al.  Measuring inconsistency in meta-analyses , 2003, BMJ : British Medical Journal.

[5]  Y. Ben-Shlomo,et al.  An investigation of fetal, postnatal and childhood growth with insulin‐like growth factor I and binding protein 3 in adulthood , 2003, Clinical endocrinology.

[6]  E. Riboli,et al.  Circulating levels of insulin‐like growth factor I, its binding proteins ‐1,‐2, ‐3, C‐peptide and risk of postmenopausal breast cancer , 2003, International journal of cancer.

[7]  A. Juul.  Serum levels of insulin-like growth factor I and its binding proteins in health and disease. , 2003, Growth hormone & IGF research : official journal of the Growth Hormone Research Society and the International IGF Research Society.

[8]  H. Iwata,et al.  Insulin, insulin-like growth factor-I and breast cancer risk in Japanese women. , 2003, Asian Pacific journal of cancer prevention : APJCP.

[9]  T. Peters,et al.  Are diet–prostate cancer associations mediated by the IGF axis? A cross-sectional analysis of diet, IGF-I and IGFBP-3 in healthy middle-aged men , 2003, British Journal of Cancer.

[10]  D. Botstein,et al.  Discovering genotypes underlying human phenotypes: past successes for mendelian disease, future approaches for complex disease , 2003, Nature Genetics.

[11]  A. Hofman,et al.  A polymorphism in the IGF-I gene influences the age-related decline in circulating total IGF-I levels. , 2003, European journal of endocrinology.

[12]  N. Probst-Hensch,et al.  IGF1 genotype, mean plasma level and breast cancer risk in the Hawaii/Los Angeles multiethnic cohort , 2003, British Journal of Cancer.

[13]  P. Gregersen,et al.  Frequency of CHEK2*1100delC in New York breast cancer cases and controls , 2003, BMC Medical Genetics.

[14]  R. Krajcik,et al.  Insulin-like growth factor I (IGF-I), IGF-binding proteins, and breast cancer. , 2002, Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology.

[15]  Jianfeng Xu,et al.  Positive results in association studies are associated with departure from Hardy-Weinberg equilibrium: hint for genotyping error? , 2002, Human Genetics.

[16]  F. Berrino,et al.  Fasting glucose is a risk factor for breast cancer: a prospective study. , 2002, Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology.

[17]  D. Hunter,et al.  Dinucleotide repeat in the insulin-like growth factor-I gene is not related to risk of colorectal adenoma. , 2002, Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology.

[18]  M. Papa,et al.  Insulin-like growth factor I polymorphism and breast cancer risk in Jewish women. , 2002, The Israel Medical Association journal : IMAJ.

[19]  S. Hankinson,et al.  Lifestyle correlates of plasma insulin-like growth factor I and insulin-like growth factor binding protein 3 concentrations. , 2002, Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology.

[20]  X. Shu,et al.  Insulin-like growth factors and breast cancer risk in Chinese women. , 2002, Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology.

[21]  M. Spitz,et al.  Plasma concentrations of insulin-like growth factors among healthy adult men and postmenopausal women: associations with body composition, lifestyle, and reproductive factors. , 2002, Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology.

[22]  F. Speizer,et al.  A sequence repeat in the insulin‐like growth factor‐1 gene and risk of breast cancer , 2002, International journal of cancer.

[23]  Yoav Ben-Shlomo,et al.  A putative functional polymorphism in the IGF-I gene: association studies with type 2 diabetes, adult height, glucose tolerance, and fetal growth in U.K. populations. , 2002, Diabetes.

[24]  J. Holly,et al.  What is the role of the insulin‐like growth factor system in the pathophysiology of cancer cachexia, and how is it regulated? , 2002, Clinical endocrinology.

[25]  C. M. Lewis,et al.  Genetic association studies: Design, analysis and interpretation , 2002, Briefings Bioinform..

[26]  Nazneen Rahman,et al.  Low-penetrance susceptibility to breast cancer due to CHEK2*1100delC in noncarriers of BRCA1 or BRCA2 mutations , 2002, Nature Genetics.

[27]  J. Eastham,et al.  Genotype–phenotype analysis for the polymorphic CA repeat in the insulin-like growth factor-I (IGF-I) gene , 2002, European Journal of Epidemiology.

[28]  Jung Gu Kim,et al.  The relationship among serum insulin-like growth factor-I, insulin-like growth factor-I gene polymorphism, and bone mineral density in postmenopausal women in Korea. , 2002, American journal of obstetrics and gynecology.

[29]  T. Key,et al.  Serum insulin-like growth factor I (IGF-I) concentration in men is not associated with the cytosine-adenosine repeat polymorphism of the IGF-I gene. , 2002, Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology.

[30]  E. Riboli,et al.  Prospective study of IGF-I, IGF-binding proteins, and breast cancer risk, in Northern and Southern Sweden , 2002, Cancer Causes & Control.

[31]  D. Voskuil,et al.  Determinants of circulating insulin-like growth factor (IGF)-I and IGF binding proteins 1–3 in premenopausal women: physical activity and anthropometry (Netherlands) , 2001, Cancer Causes & Control.

[32]  R. Shi,et al.  Polymorphic CA repeats in the IGF-I gene and breast cancer , 2001, Breast Cancer Research and Treatment.

[33]  J. Ioannidis,et al.  Replication validity of genetic association studies , 2001, Nature Genetics.

[34]  D. Yee,et al.  The IGF system and breast cancer. , 2001, Endocrine-related cancer.

[35]  Tom R. Gaunt,et al.  Positive associations between single nucleotide polymorphisms in the IGF2 gene region and body mass index in adult males. , 2001, Human molecular genetics.

[36]  S. Narod,et al.  Genetic and nongenetic factors associated with variation of plasma levels of insulin-like growth factor-I and insulin-like growth factor-binding protein-3 in healthy premenopausal women. , 2001, Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology.

[37]  A. Hofman,et al.  A polymorphism in the gene for IGF-I: functional properties and risk for type 2 diabetes and myocardial infarction. , 2001, Diabetes.

[38]  Hans J. Berkel,et al.  Free insulin‐like growth factor‐I and breast cancer risk , 2001 .

[39]  M. Stampfer,et al.  Novel promoter polymorphism in insulin-like growth factor-binding protein-3: correlation with serum levels and interaction with known regulators. , 2001, The Journal of clinical endocrinology and metabolism.

[40]  S. Narod,et al.  Genetic factors related to racial variation in plasma levels of insulin-like growth factor-1: implications for premenopausal breast cancer risk. , 2001, Molecular genetics and metabolism.

[41]  R. Kaaks,et al.  Energy balance and cancer: the role of insulin and insulin-like growth factor-I , 2001, The Proceedings of the Nutrition Society.

[42]  R. Shore,et al.  Serum insulin‐like growth factor‐I and breast cancer , 2000, International journal of cancer.

[43]  J R Marshall,et al.  Pooled analysis of prospective cohort studies on height, weight, and breast cancer risk. , 2000, American journal of epidemiology.

[44]  W. Willett,et al.  Plasma insulin-like growth factor (IGF) I, IGF-binding protein 3, and mammographic density. , 2000, Cancer research.

[45]  D. Trichopoulos,et al.  Leptin and insulin growth factor I in relation to breast cancer (Greece) , 2000, Cancer Causes & Control.

[46]  T. Hansen,et al.  Studies of the variability of the genes encoding the insulin-like growth factor I receptor and its ligand in relation to type 2 diabetes mellitus. , 2000, The Journal of clinical endocrinology and metabolism.

[47]  Kristen L Murphy,et al.  Cooperative interaction between mutant p53 and des(1-3)IGF-I accelerates mammary tumorigenesis , 2000, Oncogene.

[48]  G. Giles,et al.  HRAS1 rare minisatellite alleles and breast cancer in Australian women under age forty years. , 1999, Journal of the National Cancer Institute.

[49]  E. Barrett-Connor,et al.  Obesity, weight change, fasting insulin, proinsulin, C-peptide, and insulin-like growth factor-1 levels in women with and without breast cancer: the Rancho Bernardo Study. , 1999, Journal of women's health & gender-based medicine.

[50]  E. Rimm,et al.  Racial variation in insulin-like growth factor-1 and binding protein-3 concentrations in middle-aged men. , 1999, Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology.

[51]  Y. Wu,et al.  Plasma Insulin-Like Growth Factor-I and Serum IGF-Binding Protein 3 Can Be Associated with the Progression of Breast Cancer, and Predict the Risk of Recurrence and the Probability of Survival in African-American and Hispanic Women , 1999, Oncology.

[52]  A. Lethaby,et al.  Serum levels of insulin-like growth factor binding protein-3 in benign and malignant breast disease. , 1999, The Australian and New Zealand journal of surgery.

[53]  K. Zänker,et al.  Modulation of Epidermal Growth Factor Receptor Gene Transcription by a Polymorphic Dinucleotide Repeat in Intron 1* , 1999, The Journal of Biological Chemistry.

[54]  M. Westwood,et al.  Modification of plasma insulin-like growth factors and binding proteins during oral contraceptive use and the normal menstrual cycle. , 1999, American journal of obstetrics and gynecology.

[55]  Kaul Kk,et al.  Serum IGF-binding protein-6 and prostate specific antigen in breast cancer. , 1999 .

[56]  L. Maile,et al.  Active and inhibitory components of the insulin-like growth factor binding protein-3 protease system in adult serum, interstitial, and synovial fluid. , 1998, Endocrinology.

[57]  J. Bilezikian,et al.  Association between serum insulin growth factor-I (IGF-I) and a simple sequence repeat in IGF-I gene: implications for genetic studies of bone mineral density. , 1998, The Journal of clinical endocrinology and metabolism.

[58]  David J Hunter,et al.  Circulating concentrations of insulin-like growth factor I and risk of breast cancer , 1998, The Lancet.

[59]  P. Tan,et al.  Altered serum levels of insulin-like growth-factor binding proteins in breast cancer patients , 1998, Annals of Surgical Oncology.

[60]  G. Ho,et al.  Urinary 2/16 alpha-hydroxyestrone ratio: correlation with serum insulin-like growth factor binding protein-3 and a potential biomarker of breast cancer risk. , 1998, Annals of the Academy of Medicine, Singapore.

[61]  P. Sasieni.  From genotypes to genes: doubling the sample size. , 1997, Biometrics.

[62]  S. Humphries,et al.  Apal polymorphism in insulin-like growth factor II (IGF2) gene and weight in middle-aged males , 1997, International Journal of Obesity.

[63]  E. Barrett-Connor,et al.  Epidemiology of insulin-like growth factor-I in elderly men and women. The Rancho Bernardo Study. , 1997, American journal of epidemiology.

[64]  J. Kaprio,et al.  Genetic and environmental components of interindividual variation in circulating levels of IGF-I, IGF-II, IGFBP-1, and IGFBP-3. , 1996, The Journal of clinical investigation.

[65]  J. Verhaeghe,et al.  C-peptide, insulin-like growth factors I and II, and insulin-like growth factor binding protein-1 in cord serum of twins: genetic versus environmental regulation. , 1996, American journal of obstetrics and gynecology.

[66]  K. D. Hopkins,et al.  Ethnicity affects IGFBP‐3 and IGF‐II in normal healthy young adult subjects , 1996, Clinical endocrinology.

[67]  Z. Gucev,et al.  Insulin-like growth factor-binding proteins (IGFBPs) and their regulatory dynamics. , 1996, The international journal of biochemistry & cell biology.

[68]  C. Conover,et al.  Factors regulating insulin-like growth factor-binding protein-3 binding, processing, and potentiation of insulin-like growth factor action. , 1996, Endocrinology.

[69]  N. Pedersen,et al.  Quantitative genetic analyses of insulin-like growth factor I (IGF-I), IGF-binding protein-1, and insulin levels in middle-aged and elderly twins. , 1996, The Journal of clinical endocrinology and metabolism.

[70]  D. Hill,et al.  Mammary cancer in transgenic mice expressing insulin-like growth factor II (IGF-II) , 1995, British Journal of Cancer.

[71]  T. C. Linders,et al.  Insulin‐like growth‐factor‐binding protein 3 is decreased in early‐stage operable pre‐menopausal breast cancer , 1995, International journal of cancer.

[72]  S. Jahanfar,et al.  A twin study of polycystic ovary syndrome. , 1995, Fertility and sterility.

[73]  N. Skakkebaek,et al.  Serum insulin-like growth factor-I in 1030 healthy children, adolescents, and adults: relation to age, sex, stage of puberty, testicular size, and body mass index. , 1994, The Journal of clinical endocrinology and metabolism.

[74]  P. Kao,et al.  Insulin-like growth factor-I comparisons in healthy twin children. , 1994, The Journal of clinical endocrinology and metabolism.

[75]  N. Risch,et al.  An association between the risk of cancer and mutations in the HRAS1 minisatellite locus. , 1993, The New England journal of medicine.

[76]  V. Macaulay,et al.  Insulin-like growth factors and cancer. , 1992, British Journal of Cancer.

[77]  J. Chirgwin,et al.  Genetic analysis of the hypervariable region flanking the human insulin gene. , 1986, American journal of human genetics.

[78]  S. Sforzini,et al.  Insulin-like growth factor-I (IGF-I) and IGF-binding proteins blood serum levels in women with early- and late-stage breast cancer: mutual relationship and possible correlations with patients' hormonal status , 2005, Journal of Cancer Research and Clinical Oncology.

[79]  D. Campani,et al.  IGF-II mRNA and protein are expressed in the stroma of invasive breast cancers: Anin situ hybridization and immunohistochemistry study , 2005, Breast Cancer Research and Treatment.

[80]  S. Paik.  Expression of IGF-I and IGF-II mRNA in breast tissue , 2005, Breast Cancer Research and Treatment.

[81]  D. Yee,et al.  IGFs and IGFBPs in the Normal Mammary Gland and in Breast Cancer , 2004, Journal of mammary gland biology and neoplasia.

[82]  I. G. Fantus,et al.  Insulin and related factors in premenopausal breast cancer risk , 2004, Breast Cancer Research and Treatment.

[83]  Adrian V. Lee,et al.  Crosstalk Between the Insulin-Like Growth Factors and Estrogens in Breast Cancer , 2004, Journal of Mammary Gland Biology and Neoplasia.

[84]  D. Hadsell,et al.  IGF and Insulin Action in the Mammary Gland: Lessons from Transgenic and Knockout Models , 2004, Journal of Mammary Gland Biology and Neoplasia.

[85]  C. V. van Duijn,et al.  Polymorphism in the IGF-I gene: clinical relevance for short children born small for gestational age (SGA). , 2002, The Journal of clinical endocrinology and metabolism.

[86]  W. Willett,et al.  Dietary correlates of plasma insulin-like growth factor I and insulin-like growth factor binding protein 3 concentrations. , 2002, Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology.

[87]  L. Adams-Campbell,et al.  Insulin-like growth factor-1 and breast cancer risk in postmenopausal African-American women. , 2000, Cancer detection and prevention.

[88]  C. Roberts,et al.  The IGF system : molecular biology, physiology, and clinical applications , 1999 .

[89]  J. Sussenbach,et al.  Regulation of IGF Gene Expression , 1999 .

[90]  G. Ho,et al.  Serum IGF-binding protein-6 and prostate specific antigen in breast cancer. , 1999, European journal of endocrinology.

[91]  L. Phillips,et al.  Molecular regulation of insulin-like growth factor-I and its principal binding protein, IGFBP-3. , 1998, Progress in nucleic acid research and molecular biology.

[92]  J. Bonneterre,et al.  Plasma insulin-like growth factor-1 (IGF-1) concentrations in human breast cancer. , 1993, European journal of cancer.